Coronary intervention patient demographics
n=101 | |
Age (year), mean±SD | 62.29±10.12 |
Male sex, n (%) | 84 (83.2) |
Black, Asian, minority ethnic, n (%) | 58 (57.4) |
Median BMI (IQR) | 27.55 (25.14–29.39) |
Medical history, n (%) | |
Hypertension | 55 (54.4) |
Hypercholesterolaemia | 62 (61.4) |
Diabetes mellitus | 31 (30.7) |
Smoking history | 20 (19.8) |
Previous MI | 31 (30.7) |
Previous PCI | 41 (40.6) |
Previous CABG | 9 (8.9) |
LV ejection fraction (%), mean±SD | 53.70±7.27 |
Serum creatinine (μmol/L), mean±SD | 83.86±16.33 |
Elective procedure, n (%) | 72 (71.3) |
Staged procedure following ACS, n (%) | 18 (17.8) |
Angiogram±PCI for medically managed ACS | 11 (10.9) |
Femoral access, n (%) | 15 (14.9) |
Procedural type, n (%) | |
Diagnostic angiogram, n (%) | 33 (32.7) |
Medical management—no planned interventions | 12 (36.4) |
Workup for valve surgery | 1 (3) |
Investigations of troponin-positive events | 3 (9.1) |
Other surgery | 3 (9.1) |
Planned for staged PCI | 3 (9.1) |
Referral for CABG/MDT | 11 (33.3) |
Diagnostic device used, no therapeutic intervention n (%) | 14 (13.9) |
PCI, n (%) | 54 (54.5) |
left anterior descending artery | 31 (57.4) |
Left circumflex | 23 (42.6) |
Right coronary artery | 12 (22.2) |
Grafts | 2 (3.7) |
Diagnostic device used to guide PCI | 31 (57.4) |
Functional indices (FFR/iFR) | 5 (16.1) |
Intravascular ultrasound | 24 (77.4) |
Optical coherence tomography | 2 (6.4) |
Procedural complexity | |
Multivessel PCI | 11 (20.4) |
Number of stents used, mean±SD | 1.47±0.79 |
Length of segment treated (mm), mean±SD | 41.63±20.9 |
Bifurcation, n (%) | 8 (14.8) |
Instent restenosis, n (%) | 4 (7.4) |
CTO, n (%) | 4 (7.4) |
Calcium modification, n (%) | 4 (7.4) |
Rotational atherectomy | 3 (5.6) |
Intravascular llthotripsy | 1 (1.9) |
ACS, acute coronary syndrome; BMI, Body Mass Index; CABG, coronary artery bypass; LV, left ventricle; MDT, multidisciplinary team; MI, myocardial infarction; PCI, percutaneous coronary intervention.